A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples